The MAA was submitted to the EMA by Mitsubishi Tanabe Pharma GmbH under the centralized procedure, which applies to all member states of the European Union (EU), Iceland, Norway and Liechtenstein. All ...

Last month, Mitsubishi made headlines for reportedly not being very interested in participating in the now-dead merger between Nissan and Honda. When I first heard this, my hand hit my forehead.

Indian drugmakers earn a significant share of revenue from the U.S., the largest importer of Indian pharma products. India's pharma exports to the country stood at $8.73 billion in fiscal 2024 - a ...

Then came the threats of tariffs that the Indian pharma sector could face in the United States. How turbulent could the after-effects be of the possible tariffs? “The key strength of Indian ...

US tariffs on pharmaceutical imports will affect India’s pharma sector, a leader in affordable generics. Analyst Vishal Manchanda highlights risks to Indian firms like Sun Pharma and Cipla due to ...

Mitsubishi Tanabe Pharma, to the US investment firm Bain Capital for about $3.3 billion. Mitsubishi Chemical says it will invest proceeds from the sale in green specialty chemicals , which it has ...

Mitsubishi Tanabe Pharma is being sold to Bain Capital for about $3.3 billion. Eisai expects a Leqembi "expansion phase" on the horizon. And more. 1. Astellas shifts investment focus to later ...

Natco Pharma Share Price: Shares of NATCO Pharma plunged 20% on Thursday, February 13, after the company reported a decline in revenue, profit, and operating income for the third quarter of fiscal ...